Allergy & Immunology

Peanut oral immunotherapy using home-measured peanut butter significantly improves long-term desensitisation in children with high-threshold peanut allergy.

A proof-of-concept study was conducted to explore whether dupilumab could induce desensitisation to peanut in children with peanut allergy.

These findings suggest that vonoprazan and tetracycline dual therapy is both effective and well-tolerated, offering a valuable alternative.

These findings suggest that a preoperative radiation therapy boost can safely induce a short-term increase in stromal tumour-infiltrating lymphocytes.

The ability to pharmacologically degrade fat mass and obesity-associated protein represents a promising avenue for enhancing anti-tumour immunity.

Immune checkpoint inhibitors represent an exciting avenue for managing field cancerisation and reducing the keratinocyte carcinoma burden.

These findings highlight a host-intrinsic mechanism responsible for the failure of PD-L1 blockade in ovarian cancer.

The study highlights the necessity of a third vaccination to detect neutralising activity, particularly against emerging Omicron subvariants.